Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 2856 for cancer

Edit search filters
  1. A Study Of LOXO-783 In Patients With Breast Cancer/Other Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study to Analyze The Impact of Pharmacist Consultation in Patients Beginning Intravenous Cancer Treatment

    La Crosse, WI

  3. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood In Patients With Relapsed And Resistant Ovarian Cancer

    Scottsdale/Phoenix, AZ

  4. Effectiveness Of Mindfulness-Based Intervention On Patient Reported Outcomes Of Black Adult Cancer Survivors: A Community Faith-Based Mindfulness Ministry

    Jacksonville, FL

  5. A Study To Evaluate KIN-3248 In Participants With Advanced Tumors Harboring FGFR2 And//or FGFR3 Gene Alterations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Study Of LY3410738 Administered To Patients With Advanced Solid Tumors With IDH1 Or IDH2 Mutations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors

    Jacksonville, FL, Rochester, MN

  8. CJNJ-67652000 And Prednisone For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer And SPOP Gene Mutations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Trial Of Nadofaragene Firadenovec Vs. Observation In Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Study Of Ociperlimab In Combination With Tislelizumab In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer